General InformationEpicrispr Biotechnologies is a deep-tech biotech company focused on CRISPR-based therapeutics and gene editing solutions, likely founded in the 2015-2020 timeframe with a small to mid-sized team.
Funding & FinancialsSpecific funding details for Epicrispr could not be confirmed; typical CRISPR biotech companies at the deep-tech stage have raised seed to Series B funding from specialized life science VCs.
Leadership & TeamLeadership information for Epicrispr Biotechnologies could not be independently verified from available sources.
Recent ActivityRecent developments for this company could not be confirmed; CRISPR biotechs typically focus on advancing lead therapeutic candidates or expanding their patent portfolio around gene-editing applications.